Cargando…
Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG
Gastric cancer (GC) is the fifth most common malignancy and the third leading cause of cancer-associated mortality in the world. However, its mechanisms of occurrence and development have not been clearly elucidated. Furthermore, there is no effective tumor marker for GC. Using DNA microarray analys...
Autores principales: | Duan, Shijie, Gong, Baocheng, Wang, Pengliang, Huang, Hanwei, Luo, Lei, Liu, Funan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131538/ https://www.ncbi.nlm.nih.gov/pubmed/30106150 http://dx.doi.org/10.3892/mmr.2018.9368 |
Ejemplares similares
-
Novel immune–risk score of gastric cancer: A molecular prediction model combining the value of immune–risk status and chemosensitivity
por: Duan, Shijie, et al.
Publicado: (2019) -
CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer
por: Cheng, Zhenguo, et al.
Publicado: (2017) -
Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer
por: Shi, Feiyu, et al.
Publicado: (2018) -
MicroRNA-28-5p inhibits the migration and invasion of gastric cancer cells by suppressing AKT phosphorylation
por: Xiao, Fangtao, et al.
Publicado: (2018) -
Elevated Serum FGG Levels Prognosticate and Promote the Disease Progression in Prostate Cancer
por: Peng, H. H., et al.
Publicado: (2021)